Testing for Chlamydia and Gonorrhea in Bacterial Vaginosis
Rationale for Concurrent Testing
- The Centers for Disease Control and Prevention (CDC) recommends that all patients tested for gonorrhea should be tested for other STDs, including chlamydia, syphilis, and HIV, due to high coinfection rates and asymptomatic presentation of these infections 1
- Both chlamydia and gonorrhea are frequently asymptomatic in women, yet can progress to pelvic inflammatory disease, tubal scarring, infertility, and ectopic pregnancy if left untreated 1
- Women presenting with vaginal symptoms often have risk factors for both bacterial vaginosis and STIs, highlighting the need for concurrent testing 2, 3, 4
Risk-Based Testing Algorithm
- The American College of Physicians recommends mandatory annual screening for chlamydia and gonorrhea in sexually active women under 25 years, as this is the highest risk group 5
- The CDC recommends testing for chlamydia and gonorrhea in women aged 25 years or older with risk factors, such as new or multiple sex partners, inconsistent condom use, previous STI, or partner with STI 1, 5
- Testing is also recommended in high-prevalence settings, such as STD clinics or certain geographic areas, and in patients with uncertain follow-up 1, 7, 8
Testing Methodology
- The CDC recommends using nucleic acid amplification tests (NAATs) as the preferred diagnostic method for chlamydia and gonorrhea, due to their high sensitivity and specificity 5, 6
- NAATs can be used to test for both pathogens using the same specimen, such as a cervical swab, vaginal swab, or urine sample 5
- Self-collected vaginal swabs are acceptable and FDA-cleared for use with NAATs 5
Treatment Considerations
- The CDC recommends awaiting test results before treating for chlamydia or gonorrhea, unless the patient is high-risk or unlikely to return for follow-up 8, 7
- In high-prevalence settings, presumptive treatment with azithromycin or doxycycline may be considered before test results are available 6
- The presence of clue cells warrants treatment for bacterial vaginosis, regardless of STI testing results 2, 3, 4
Partner Management
- The CDC recommends that all sex partners from the past 60 days be notified, examined, and treated if chlamydia or gonorrhea is diagnosed 6
- Both patients and partners must abstain from intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen, and retesting is recommended at 3 months to detect reinfection 6
Special Populations
- The American College of Obstetricians and Gynecologists recommends screening pregnant women for chlamydia and gonorrhea at the first prenatal visit and third trimester, and treating with azithromycin or amoxicillin if positive 6